Terumo completed the acquisition of OrganOx for $1.5bn.

Terumo, a global medical device company, completed the acquisition of OrganOx, a commercial-stage organ technology company, for $1.5bn. “This transaction represents an important milestone for OrganOx and its shareholders. We look forward to continuing our rich history of collaboration with Terumo to continue harnessing our collective innovations to improve patient care,” Craig Marshall, OrganOx CEO.